NCT00003433View on ClinicalTrials.gov

Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1998

Study Completion Date

August 31, 2003

Conditions
Colorectal CancerMetastatic Cancer
Interventions
BIOLOGICAL

carcinoembryonic antigen RNA-pulsed DC cancer vaccine

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke Cancer Institute

OTHER

NCT00003433 - Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer | Biotech Hunter | Biotech Hunter